Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Impax Laboratories Inc (IPXL)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2018 Q2 | 0 | 0.00 | Sell 100.00% | 1.06 | SEC | ||
| 2018 Q1 | 4,043,203 | 1.06 | Reduce 44.82% | 0.73 | $19.45 | $78,640,000 | SEC |
| 2017 Q4 | 7,327,798 | 1.63 | Add 12.83% | 0.19 | $16.65 | $122,008,000 | SEC |
| 2017 Q3 | 6,494,298 | 1.75 | Reduce 9.29% | 0.13 | $20.30 | $131,834,000 | SEC |
| 2017 Q2 | 7,159,336 | 1.45 | Add 6,705.45% | 1.43 | $16.10 | $115,265,000 | SEC |
| 2017 Q1 | 105,200 | 0.02 | Buy | 0.02 | $12.65 | $1,331,000 | SEC |